Literature DB >> 18216779

Increased workload fully activates the blunted IRS-1/PI3-kinase/Akt signaling pathway in atrophied uremic muscle.

Y Chen1, S Sood, J Biada, R Roth, R Rabkin.   

Abstract

Muscle wasting in chronic renal failure is associated with increased morbidity and mortality; however, resistance exercise is effective at increasing muscle mass while improving muscle strength and function. To study the mechanism by which this occurs, we compared uremic and control rats where work overload was surgically induced unilaterally in the plantaris muscle. We found that work overload increases muscle insulin-like growth factor-1 and mechano-growth factor expression. This in addition to direct mechanical activation of signaling was likely the cause of the observed increased in the protein levels and phosphorylation of the mediators of these growth factors, the insulin receptor substrate-1/phosphoinositide 3-kinase/Akt pathway. The mechanical enhancement of signal transduction appeared to be mediated in part by increased signal protein levels and decreased SOCS2 mRNA expression (suppressor of cytokine signaling-2). Despite impaired basal signaling, the work-induced signaling response was similar to that observed in nonuremic rats and produced changes consistent with decreased muscle protein degradation, increased protein synthetic capacity, and an increased number of multinucleated muscle cells. Our studies suggest that these work-induced changes account for the improved uremic muscle mass reaching levels comparable to those seen in normal rats.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18216779     DOI: 10.1038/sj.ki.5002801

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  15 in total

Review 1.  Mechanisms of muscle wasting in chronic kidney disease.

Authors:  Xiaonan H Wang; William E Mitch
Journal:  Nat Rev Nephrol       Date:  2014-07-01       Impact factor: 28.314

2.  Glucocorticoid-Regulated Kinase: Linking Azotemia and Muscle Wasting in CKD.

Authors:  Madhav C Menon; John Cijiang He
Journal:  J Am Soc Nephrol       Date:  2016-04-08       Impact factor: 10.121

3.  Combining exercise and growth hormone therapy: how can we translate from animal models to chronic kidney disease children?

Authors:  Justine Bacchetta; Isidro B Salusky
Journal:  Nephrol Dial Transplant       Date:  2016-01-31       Impact factor: 5.992

Review 4.  Ribosome biogenesis: emerging evidence for a central role in the regulation of skeletal muscle mass.

Authors:  Thomas Chaillou; Tyler J Kirby; John J McCarthy
Journal:  J Cell Physiol       Date:  2014-11       Impact factor: 6.384

5.  A marked deficiency in circulating and renal IGF-I peptide does not inhibit compensatory renal enlargement in uninephrectomized mice.

Authors:  Daniel Landau; Jaclyn Biada; Yu Chen; Sumita Sood; Shoshanah Yakar; Derek Leroith; Yael Segev; Ralph Rabkin
Journal:  Growth Horm IGF Res       Date:  2011-08-23       Impact factor: 2.372

6.  TGF-β inhibits muscle differentiation by blocking autocrine signaling pathways initiated by IGF-II.

Authors:  Samantha Gardner; Damir Alzhanov; Paul Knollman; David Kuninger; Peter Rotwein
Journal:  Mol Endocrinol       Date:  2010-11-24

7.  Exercise ameliorates chronic kidney disease-induced defects in muscle protein metabolism and progenitor cell function.

Authors:  Xiaonan H Wang; Jie Du; Janet D Klein; James L Bailey; William E Mitch
Journal:  Kidney Int       Date:  2009-07-29       Impact factor: 10.612

Review 8.  Regulation of muscle protein synthesis and the effects of catabolic states.

Authors:  Bradley S Gordon; Andrew R Kelleher; Scot R Kimball
Journal:  Int J Biochem Cell Biol       Date:  2013-06-12       Impact factor: 5.085

9.  Insulin resistance and muscle metabolism in chronic kidney disease.

Authors:  James L Bailey
Journal:  ISRN Endocrinol       Date:  2013-02-03

10.  Acupuncture plus Low-Frequency Electrical Stimulation (Acu-LFES) Attenuates Diabetic Myopathy by Enhancing Muscle Regeneration.

Authors:  Zhen Su; Alayna Robinson; Li Hu; Janet D Klein; Faten Hassounah; Min Li; Haidong Wang; Hui Cai; Xiaonan H Wang
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.